• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients.新型冠状病毒肺炎患者的高铁蛋白血症与毛霉病程度
Cureus. 2021 Dec 21;13(12):e20569. doi: 10.7759/cureus.20569. eCollection 2021 Dec.
2
Effect of High Serum Ferritin on Extent of Involvement of COVID-19 Associated Mucormycosis.高血清铁蛋白对新型冠状病毒肺炎相关毛霉病累及范围的影响
Indian J Otolaryngol Head Neck Surg. 2024 Apr;76(2):1857-1861. doi: 10.1007/s12070-023-04428-3. Epub 2023 Dec 19.
3
Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.血清铁研究与 COVID 相关毛霉菌病疾病阶段的相关性。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
4
Is Serum Ferritin an Early Marker for COVID-19-Associated Mucormycosis?血清铁蛋白是新型冠状病毒肺炎相关毛霉病的早期标志物吗?
Cureus. 2023 Mar 27;15(3):e36734. doi: 10.7759/cureus.36734. eCollection 2023 Mar.
5
Estimation of Serum Ferritin in Mucormycosis Patients and Prognostication Based on the Ferritin Value.毛霉菌病患者血清铁蛋白的测定及基于铁蛋白值的预后评估。
Cureus. 2022 Apr 10;14(4):e24013. doi: 10.7759/cureus.24013. eCollection 2022 Apr.
6
Cross-sectional study to describe the severity, bio-chemical associations, and final outcomes of COVID-19-associated rhino-orbital-cerebral mucormycosis in a tertiary hospital of East India.在印度东部的一家三级医院进行的横断面研究,旨在描述 COVID-19 相关的鼻-眶-脑毛霉菌病的严重程度、生物化学关联和最终结局。
Indian J Ophthalmol. 2023 May;71(5):2193-2198. doi: 10.4103/IJO.IJO_2507_22.
7
Increased serum ferritin is associated with severity of orbital disease in COVID-19-associated rhino-orbito-cerebral mucormycosis: A quantitative analysis.血清铁蛋白升高与新型冠状病毒肺炎相关鼻眶脑毛霉菌病眼眶疾病的严重程度相关:一项定量分析。
Indian J Ophthalmol. 2025 Feb 1;73(2):223-227. doi: 10.4103/IJO.IJO_574_23. Epub 2024 Jul 11.
8
Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study.导致 COVID-19 引发鼻-眶-脑毛霉菌病的发病因素:一项观察性研究。
J Mycol Med. 2022 May;32(2):101252. doi: 10.1016/j.mycmed.2022.101252. Epub 2022 Feb 1.
9
COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review.COVID-19 相关毛霉菌病:一种机会性真菌感染。病例系列和综述。
Int J Infect Dis. 2022 Aug;121:203-210. doi: 10.1016/j.ijid.2022.05.005. Epub 2022 May 6.
10
Role of COVID 19 Inflammatory Markers in Rhino-Orbito-Cerebral Mucormycosis: A Case Study in Predisposed Patients at a Designated Nodal Centre.新型冠状病毒肺炎炎症标志物在鼻眶脑型毛霉病中的作用:指定节点中心易感患者的病例研究
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3498-3504. doi: 10.1007/s12070-021-02970-6. Epub 2021 Nov 13.

引用本文的文献

1
Analysis of the clinical parameters and management aspects of rhino-maxillary mucormycosis, Part I: challenges in diagnosis.鼻上颌毛霉菌病的临床参数及管理方面分析,第一部分:诊断挑战
BMC Oral Health. 2025 Jul 31;25(1):1286. doi: 10.1186/s12903-025-05842-5.
2
Association of Markers of iron Metabolism with Mucormycosis: A Case Control Study.铁代谢标志物与毛霉病的关联:一项病例对照研究。
Indian J Otolaryngol Head Neck Surg. 2025 Jun;77(6):2344-2351. doi: 10.1007/s12070-025-05506-4. Epub 2025 May 5.
3
Epidemiology, pathogenesis, clinical characteristics, and treatment of mucormycosis: a review.棘白菌素类药物在侵袭性曲霉菌病治疗中的作用。
Ann Med. 2024 Dec;56(1):2396570. doi: 10.1080/07853890.2024.2396570. Epub 2024 Sep 2.
4
Effect of High Serum Ferritin on Extent of Involvement of COVID-19 Associated Mucormycosis.高血清铁蛋白对新型冠状病毒肺炎相关毛霉病累及范围的影响
Indian J Otolaryngol Head Neck Surg. 2024 Apr;76(2):1857-1861. doi: 10.1007/s12070-023-04428-3. Epub 2023 Dec 19.
5
Association of COVID with Mycosis in General.一般情况下 COVID 与真菌感染的关联。
Infect Disord Drug Targets. 2024;24(6):e190124225866. doi: 10.2174/0118715265266815231130063931.
6
Clinical profile, prognostic factors, and outcomes of rhino-orbital-cerebral mucormycosis in the setting of COVID-19: A retrospective study.2019冠状病毒病背景下鼻眶脑型毛霉病的临床特征、预后因素及结局:一项回顾性研究
Saudi J Ophthalmol. 2023 May 26;37(2):100-106. doi: 10.4103/sjopt.sjopt_155_22. eCollection 2023 Apr-Jun.
7
Is Serum Ferritin an Early Marker for COVID-19-Associated Mucormycosis?血清铁蛋白是新型冠状病毒肺炎相关毛霉病的早期标志物吗?
Cureus. 2023 Mar 27;15(3):e36734. doi: 10.7759/cureus.36734. eCollection 2023 Mar.
8
Frequency and survival of Covid associated mucormycosis patients at tertiary care hospitals in Pakistan: A retrospective observational study.巴基斯坦三级医院新冠肺炎相关毛霉菌病患者的发病率及生存率:一项回顾性观察研究。
Health Sci Rep. 2023 Feb 3;6(2):e1083. doi: 10.1002/hsr2.1083. eCollection 2023 Feb.
9
Epidemiological Characteristics, Pathogenesis and Clinical Implications of Sinusitis in the Era of COVID-19: A Narrative Review.COVID-19时代鼻窦炎的流行病学特征、发病机制及临床意义:一项叙述性综述
J Asthma Allergy. 2023 Jan 27;16:201-211. doi: 10.2147/JAA.S398686. eCollection 2023.
10
COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.COVID-19 相关霉菌感染:COVID-19 相关肺曲霉病和毛霉菌病的综述。
J Microbiol Immunol Infect. 2023 Jun;56(3):442-454. doi: 10.1016/j.jmii.2022.12.004. Epub 2022 Dec 15.

本文引用的文献

1
COVID19 associated mucormycosis: Is GRP78 a possible link?COVID19 相关毛霉病:GRP78 是否是一个可能的联系?
J Infect Public Health. 2021 Oct;14(10):1351-1357. doi: 10.1016/j.jiph.2021.09.004. Epub 2021 Sep 10.
2
Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis.连点成线:新型冠状病毒肺炎与毛霉病致病机制之间的相互作用
J Fungi (Basel). 2021 Jul 29;7(8):616. doi: 10.3390/jof7080616.
3
Mucormycosis and COVID-19: An epidemic within a pandemic in India.毛霉菌病与 COVID-19:印度大流行中的一场流行病。
Mycoses. 2021 Oct;64(10):1253-1260. doi: 10.1111/myc.13353. Epub 2021 Jul 24.
4
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病:全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
5
Sino-orbital mucormycosis in a COVID-19 patient: A case report.一名新冠肺炎患者的鼻窦眼眶毛霉菌病:病例报告
Int J Surg Case Rep. 2021 May;82:105957. doi: 10.1016/j.ijscr.2021.105957. Epub 2021 May 4.
6
Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials.皮质类固醇在2019冠状病毒病中的治疗作用:对注册临床试验的系统评价
Futur J Pharm Sci. 2021;7(1):67. doi: 10.1186/s43094-021-00217-3. Epub 2021 Mar 17.
7
The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators.铁在 COVID-19 发病机制中的作用及乳铁蛋白和其他铁螯合剂的可能治疗作用。
Biomed Pharmacother. 2021 Apr;136:111228. doi: 10.1016/j.biopha.2021.111228. Epub 2021 Jan 13.
8
Ferritin as a Marker of Severity in COVID-19 Patients: A Fatal Correlation.铁蛋白作为新冠病毒肺炎患者病情严重程度的标志物:一种致命的关联
Isr Med Assoc J. 2020 Aug;22(8):494-500.
9
Iron Assimilation during Emerging Infections Caused by Opportunistic Fungi with emphasis on Mucorales and the Development of Antifungal Resistance.机遇性真菌引起的新兴感染期间的铁吸收,重点是毛霉目真菌及抗真菌药物耐药性的发展。
Genes (Basel). 2020 Oct 30;11(11):1296. doi: 10.3390/genes11111296.
10
Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective observational cohort study.在 COVID-19 中持续存在的铁稳态紊乱与肺部病理无法消退和患者预后不良有关:一项前瞻性观察队列研究。
Respir Res. 2020 Oct 21;21(1):276. doi: 10.1186/s12931-020-01546-2.

新型冠状病毒肺炎患者的高铁蛋白血症与毛霉病程度

Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients.

作者信息

Bhadania Simple, Bhalodiya Neena, Sethi Yashendra, Kaka Nirja, Mishra Swati, Patel Neil, Wasim Asad Ullah, Joshi Saumya S, Shah Kenisha

机构信息

Otorhinolaryngology, Gujarat Medical Education & Research Society (GMERS) Medical College Sola, Ahmedabad, IND.

Medicine, Government Doon Medical College, Dehradun, IND.

出版信息

Cureus. 2021 Dec 21;13(12):e20569. doi: 10.7759/cureus.20569. eCollection 2021 Dec.

DOI:10.7759/cureus.20569
PMID:35103148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8772619/
Abstract

Introduction Coronavirus disease 2019 (COVID-19) disease attributed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown associations with various fungal opportunistic infections such as mucormycosis, invasive candidiasis, and aspergillosis, which have contributed to the mortality of the disease. In India, the incidence of mucormycosis had risen rapidly during the second wave. There is ample literature demonstrating the role of iron in the pathogenesis of mucormycosis. The hyperferritinemia associated with COVID-19 may have played a significant role in promoting the invasion and extent of the fungus. Aims and objectives The study aimed to analyze the association between serum ferritin levels and the extent of involvement of mucormycosis in patients affected with COVID-19. Methodology A single-center cross-sectional study was conducted using retrospective hospital record data. G*Power statistical analysis software was used to compute the sample size of 62 (31+31). The radiological data were used to determine the extent of involvement. Results A statistically significant difference was seen in levels of serum ferritin (p = 0.008) between the radiologically judged two groups of the mild extent of invasion of mucormycosis (rhinosinusitis) and severe extent of invasion (rhino-orbital/cerebral mucormycosis), with a severe extent seen with the group having higher levels of serum ferritin. Severe extent of invasion was seen in 53.6% of patients with diabetes mellitus and 62.5% of patients with both diabetes and hypertension. Conclusion The hyperferritinemia not only presents as a marker of the systemic inflammatory process in COVID-19 but also indicates increased free iron, which thereby aids the growth and extent of involvement by the fungus ( ). In individuals with diabetes and hypertension, the severity was greater. Controlling catastrophic outcomes in individuals with high serum ferritin levels necessitates extra caution.

摘要

引言 2019 冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的疾病,已显示出与各种真菌机会性感染相关,如毛霉菌病、侵袭性念珠菌病和曲霉病,这些感染导致了该疾病的死亡率。在印度,第二波疫情期间毛霉菌病的发病率迅速上升。有大量文献证明铁在毛霉菌病发病机制中的作用。与 COVID-19 相关的高铁蛋白血症可能在促进真菌的侵袭和扩散方面发挥了重要作用。目的 本研究旨在分析 COVID-19 患者血清铁蛋白水平与毛霉菌病受累程度之间的关联。方法 使用回顾性医院记录数据进行单中心横断面研究。使用 G*Power 统计分析软件计算样本量为 62(31 + 31)。放射学数据用于确定受累程度。结果 在放射学判断的两组毛霉菌病轻度侵袭(鼻-鼻窦炎)和重度侵袭(鼻-眶/脑毛霉菌病)中,血清铁蛋白水平存在统计学显著差异(p = 0.008),血清铁蛋白水平较高的组显示为重度侵袭。53.6% 的糖尿病患者和 62.5% 的糖尿病合并高血压患者出现重度侵袭。结论 高铁蛋白血症不仅是 COVID-19 全身炎症过程的标志物,还表明游离铁增加,从而有助于真菌的生长和受累程度( )。在糖尿病和高血压患者中,病情更严重。对血清铁蛋白水平高的个体控制灾难性后果需要格外谨慎。